Drawing for ALLTURIO

USPTO serial 79336698

ALLTURIO

Reviewed by CopyMark Law Group

Reg. 7051247Status 700Registered
Filing date
Status date
Registration date
May 16, 2023
Examiner
SMITH, CYNTHIA RINALDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALLTURIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diane B. Melnick

Diane B. Melnick Practus LLPP.O. Box 1101New York, NY 10028UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Advertising; commercial business administration, organization and management; providing office functions; market analysis and marketing research; data processing services in the field of clinical research and development of pharmaceuticals, biotechnologies and medical devices; providing office functions, namely, preparation and submission of regulatory documents in the fields of pharmaceuticals, biotechnologies and medical devicesACTIVE—
042Scientific research in the pharmaceutical, biotechnology and medical fields; industrial analysis, being industrial research in the pharmaceutical, biotechnology and medical fields; industrial design services; quality control for others; authentication of data in the pharmaceutical, biotechnology and medical fields using blockchain technology; scientific research in the fields of engineering and information technology and consultancy therefor; provision of information relating to scientific and technological research and development in the pharmaceutical, biotechnology and medical fields; conducting clinical trials for others; research and development in the fields of pharmaceuticals, biotechnology and medical devices; provision of advice in the field of clinical research in the fields of pharmaceuticals, biotechnology and medical devices; provision of advice in the field of product development of pharmaceuticals, biotechnologies and medical devices; providing information in the field of clinical research in the fields of pharmaceuticals, biotechnology and medical devices; providing information in the field of product development of pharmaceuticals, biotechnologies and medical devices via Internet sites; scientific research, testing and analysis services in the pharmaceutical, biotechnology and medical fieldsACTIVE—
045Regulatory compliance auditing; legal compliance auditing; intellectual property consultancy; regulatory compliance consulting in the field of government approval for pharmaceuticals, biotechnologies and medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 6, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 20, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 20, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 16, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 16, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 16, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 8, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2022RFNTREFUSAL PROCESSED BY IB—
Aug 1, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 1, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2022DOCKASSIGNED TO EXAMINER—
May 14, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 29, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance